News
Asker’s $888.1 million IPO on the Nasdaq Stockholm is the largest healthcare IPO of the year so far, according to the DNB and Back Bay report. That could bode well for commercial-stage Caris.
5d
Dealbreaker on MSNPrecision Medicine Firm Caris Breaks Bio IPO Drought, Raising $494M for Cancer Analysis ToolsAs a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical ...
A high-level overview of Passage Bio, Inc. (PASG) stock. View ... IPO Update: Passage Bio Finalizes $126 Million IPO Plan ... Is Passage Bio, Inc. listed on the NASDAQ or NYSE?
Minovia’s lead product is MNV-201, an autologous hematopoietic stem cell product that is enriched with allogeneic ...
A high-level overview of Generation Bio Co. (GBIO) stock. View (GBIO) real-time stock price, chart, news, analysis, analyst reviews and more.
A high-level overview of Q32 Bio Inc. (QTTB) stock. View (QTTB) real-time stock price, chart, news, analysis, analyst reviews and more.
Get the annual and quarterly balance sheet of Adicet Bio, Inc. (ACET) including details of assets, liabilities and shareholders' equity.
A high-level overview of Precision BioSciences, Inc. (DTIL) stock. View (DTIL) real-time stock price, chart, news, analysis, analyst reviews and more.
A high-level overview of Unity Biotechnology, Inc. (UBX) stock. View (UBX) real-time stock price, chart, news, analysis, analyst reviews and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results